1222 lines
28 KiB
HTML
1222 lines
28 KiB
HTML
<!doctype html public "-//W3C//DTD HTML 4.01 Transitional//EN">
|
|
<html lang="en">
|
|
|
|
|
|
<head>
|
|
|
|
|
|
<title>NLM Classification, 5th Edition, Additions and Changes, List 2. NLM Technical Bulletin. Nov-Dec 1997</title>
|
|
|
|
<meta name="DC.Subject.IssueNum" content="299" />
|
|
<meta name="DC.Subject.IssueCover" content="/pubs/techbull/nd97/nd97_technote.html" />
|
|
|
|
|
|
<!--do not remove!! nlm survey script - contact wwwnlm@nlm.nih.gov with questions -->
|
|
<script src="/share/scripts/survey.js" type="text/javascript" language="javascript"></script>
|
|
<meta name="DC.Subject.Keyword" content="Animal" />
|
|
<meta name="DC.Subject.Keyword" content="Cancer" />
|
|
<meta name="DC.Subject.Keyword" content="Cataloging" />
|
|
<meta name="DC.Subject.Keyword" content="Chemistry" />
|
|
<meta name="DC.Subject.Keyword" content="Copyright Information" />
|
|
<meta name="DC.Subject.Keyword" content="Drug Therapy" />
|
|
<meta name="DC.Subject.Keyword" content="ELHILL" />
|
|
<meta name="DC.Subject.Keyword" content="Evidence-Based Medicine" />
|
|
<meta name="DC.Subject.Keyword" content="General Note" />
|
|
<meta name="DC.Subject.Keyword" content="Genetics" />
|
|
<meta name="DC.Subject.Keyword" content="MeSH Terms" />
|
|
<meta name="DC.Subject.Keyword" content="National Cancer Institute" />
|
|
<meta name="DC.Subject.Keyword" content="NLM Classification" />
|
|
<meta name="DC.Subject.Keyword" content="PubMed" />
|
|
<meta name="DC.Subject.Keyword" content="Systematic Reviews" />
|
|
<meta name="DC.Subject.Keyword" content="Training" />
|
|
<meta name="DC.Subject.Keyword" content="Update" />
|
|
</head>
|
|
|
|
|
|
|
|
|
|
|
|
<body bgcolor="#f0f0f0" link="#083184" vlink="#960044"><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MT6MLL" height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-MT6MLL');</script>
|
|
<style type="text/css">
|
|
#skip, .skip, .skipnavigation {
|
|
position:absolute;
|
|
left:0px;
|
|
top:-500px;
|
|
width:1px;
|
|
height:1px;
|
|
overflow:hidden;
|
|
}
|
|
</style>
|
|
<div class="skipnavigation"><a title="Skip the navigation on this page" href="#skipnav" class="skipnavigation">Skip Navigation Bar</a></div>
|
|
|
|
|
|
|
|
|
|
|
|
<a href="/nlmhome.html"><img src="/pubs/techbull/tb_graphics/tbhead4.gif" border=0 alt="NLM Technical Bulletin"/></a>
|
|
|
|
|
|
|
|
|
|
|
|
<h3><em>NLM Technical Bulletin</em> 1997 Nov-Dec; 299</h3>
|
|
|
|
|
|
|
|
|
|
|
|
<hr />
|
|
|
|
|
|
<a id="skipnav" name="skipnav"></a>
|
|
<table border=0 cellspacing=0 cellpadding=10>
|
|
|
|
|
|
<tr>
|
|
|
|
|
|
<td valign=top bgcolor="#CB9966" width=140>
|
|
|
|
|
|
<hr />
|
|
|
|
|
|
<center><strong>In This Issue:</strong></center>
|
|
|
|
|
|
<hr />
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
<a href="nd97_web.html">TB on the Web</a>
|
|
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
<a href="nd97_nci.html">NCI's CancerNet Web Site</a>
|
|
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
<a href="nd97_trans.html">Transitioning from ELHILL to PubMed</a>
|
|
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
<img src="/pubs/techbull/tb_graphics/blutri.gif" alt="dot" height=10 width=10/> NLM Classification, 5th Edition, Additions and Changes, List 2 [corrected 1998/03/26]
|
|
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
<a href="nd97_technote.html">Technical Notes</a>
|
|
|
|
|
|
</p>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/current_issue.html">Current Issue</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/tb.html">Home</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/back_issues.html">Back Issues</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/new_index.html">Index</a></strong></center>
|
|
<hr />
|
|
</td>
|
|
|
|
|
|
|
|
|
|
|
|
<td valign=top width=440>
|
|
|
|
|
|
|
|
|
|
|
|
<center><h2>NLM Classification, 5th Edition, Additions and Changes, List 2 [corrected 1998/03/26] </h2></center>
|
|
|
|
<center>[published erratum appears in <a href="/pubs/techbull/jf98/jf98_technote.html"><em>NLM Technical Bulletin.</em> 1997 Jan-Feb; (300): e1]</a></center>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
The following additions and changes to the fifth edition of the NLM Classification have been made since the issuance of Additions and Changes, List 1, announced in the January-April 1996 issue of the <em>Technical Bulletin</em>. The Cataloging Section conducted a systematic review of the new 1996 and 1997 MeSH terms to determine the need for additions and changes to the classification. The resulting additions and changes are presented in chart form in the following categories: New Table G Numbers Added, Additions/Changes to the Main Schedules, Additions in the Index, and Notable Changes in the Index.
|
|
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
Questions may be referred to Christa Hoffmann at 301-496-7135.
|
|
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
|
|
<dd><em>--prepared by Wen-Min Kao</em></dd>
|
|
|
|
|
|
<dd><em>Technical Services Division</em></dd>
|
|
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<pre>
|
|
|
|
|
|
<strong>New Table G Numbers Added</strong>
|
|
|
|
AS9 - Southeastern United States
|
|
|
|
AS95 - Southwestern United States
|
|
|
|
DC3 - Caribbean Region
|
|
|
|
DG4 - Grenada
|
|
|
|
FG9 - Guernsey
|
|
|
|
GM35 - Mediterranean Region
|
|
|
|
JQ2 - Qatar
|
|
|
|
<strong>Additions/Changes in the Main Schedules</strong>
|
|
|
|
Note: In the chart below, new numbers and their associated
|
|
headings are <em>italicized.</em>
|
|
|
|
<strong>Page Reference Change/Addition</strong>
|
|
|
|
<em>p. 39 at QW 525.5 add .I36 Immunophenotyping</em>
|
|
|
|
p. 48 at QY 21 Medical change to: QY 21 Medical as
|
|
technology a profession. laboratory technology as a
|
|
Ethics. Peer review profession. Ethics. Peer review
|
|
|
|
p. 48 at *QY 22 change to: *QY 22 Directories
|
|
Directories of medical of medical laboratory
|
|
technology (Table G) technology (Table G)
|
|
|
|
p. 48 at *QY 22.1 change to: *QY 22.1
|
|
Directories of medical Directories of medical laboratory
|
|
technology (Not Table G) technology (Not Table G)
|
|
|
|
<em>p. 60 add W 82 Medical technology
|
|
(General)</em>
|
|
|
|
<em>p. 60 add W 83 Telemedicine
|
|
(General) (Table G)</em>
|
|
|
|
<em>add W 83.1 General coverage (Not Table G)</em>
|
|
|
|
<em>p. 67 add WA 30.5 Environmental
|
|
medicine. Environmental illness</em>
|
|
|
|
<em>p. 69 add WA 330 Adolescent
|
|
health services</em>
|
|
|
|
<em>p. 96 at WD 200.5 add .I7 Iron metabolism
|
|
disorders</em>
|
|
|
|
<em>p. 110 at WF 141.5 add .C2 Capnography</em>
|
|
|
|
<em>p. 117 at WG 166.5 add .A3 Angioplasty</em>
|
|
|
|
<em>p. 161 at WM 420.5 add .I3 Imagery
|
|
(Psychotherapy)</em>
|
|
|
|
<em>p. 174 add WO 505 Endoscopic
|
|
surgery</em>
|
|
|
|
<em>p. 208 add WU 460 Dental care
|
|
for the chronically ill</em>
|
|
|
|
<em>p. 229 add WY 86.5 Holistic nursing</em>
|
|
|
|
<em>p. 230 add WY 150.5 Rehabilitation
|
|
nursing</em>
|
|
|
|
|
|
<strong>Additions in the Index</strong>
|
|
|
|
|
|
Note: In the chart below, index entries for new numbers
|
|
added are <em>italicized.</em>
|
|
|
|
Accidents, Radiation
|
|
In industry WA 470
|
|
|
|
Acupressure WB 537
|
|
|
|
<em>Adolescent Health Services WA 330</em>
|
|
|
|
Anatomy, Cross-Sectional QS 4
|
|
See also special organs or systems under Anatomy
|
|
|
|
Anesthetics, Combined
|
|
|
|
For general anesthesia QV 81
|
|
|
|
<em>Angioplasty WG 166.5.A3</em>
|
|
In the treatment of a particular disease, with the
|
|
disease
|
|
See also Endarterectomy WG 170
|
|
|
|
Anti-Allergic Agents QV 157
|
|
|
|
Anti-Asthmatic Agents QV 120
|
|
|
|
Antibiotic Prophylaxis
|
|
General QV 350
|
|
In surgery WO 178-188
|
|
For prevention of specific disease, class with the
|
|
disease; for use of specific antibiotic, class with
|
|
the drug
|
|
|
|
Anti-HIV Agents QV 268.5
|
|
|
|
Anti-Obesity Agents QV 126
|
|
As appetite depressants QV 129
|
|
|
|
Antiparasitic Agents QV 250
|
|
|
|
Apoptosis QH 671
|
|
|
|
Appetite Stimulants QV 100
|
|
Used for a specific disorder, with the disorder
|
|
|
|
Aromatherapy WB 925
|
|
Used for special purposes, by subject
|
|
|
|
Beta Carotene QU 110
|
|
As a coloring agent WA 712
|
|
Vitamin A related QU 167
|
|
|
|
Bioreactors TP 248.25.B55
|
|
Special biological systems as bioreactors, with the
|
|
system,e.g., Erythrocytes WH 150;
|
|
Animal cells TP 248.27.A53
|
|
|
|
Bone Marrow Neoplasms WH 380
|
|
|
|
Breast Implants WP 910
|
|
|
|
Bronchoalveolar Lavage WF 600
|
|
|
|
Cancer Vaccines QZ 266 [corrected 1998/03/26]
|
|
For particular neoplasms, with the neoplasm
|
|
|
|
Capillary Leak Syndrome WG 700
|
|
<em>Capnography WF 141.5.C2</em>
|
|
Used for general anesthesia monitoring WO 275
|
|
|
|
Case Management W 84.7
|
|
In nursing WY 100
|
|
|
|
Cell Culture QH 585.2-585.45
|
|
In histology QS 530
|
|
Techniques QS 525
|
|
|
|
Cell Respiration QH 633
|
|
|
|
Cells, Immobilized
|
|
Cytology QH 585.5.I45
|
|
Biotechnology TP 248.25.I55
|
|
Special topics, by subject
|
|
|
|
Chemoprevention
|
|
|
|
General WB 330
|
|
Neoplasms QZ 267
|
|
|
|
Chickenpox Vaccine WC 572
|
|
|
|
Chromosome Breakage QH 462.B7
|
|
|
|
Chronotherapy WB 340
|
|
For particular diseases, with the disease
|
|
|
|
Circumcision, Female
|
|
Anthropology GN 484
|
|
Medical procedure WP 200
|
|
|
|
Citric Acid QU 98
|
|
|
|
Color Therapy WB 890
|
|
For particular diseases, with the disease
|
|
|
|
Community Networks
|
|
In community health services WA 546
|
|
As information systems W 26.55.I4
|
|
|
|
Computational Biology QH 506
|
|
|
|
Computing Methodologies
|
|
In medicine (General) W 26.5
|
|
In other special fields (Form number 26.5 in any NLM
|
|
schedule where applicable)
|
|
Used for special purposes, by subject
|
|
|
|
Condoms WJ 710
|
|
|
|
Condoms, Female WP 640
|
|
|
|
Contraception Behavior
|
|
General works HQ 766
|
|
|
|
Couples Therapy WM 430.5.M3
|
|
|
|
Craniofacial Abnormalities WE 705
|
|
|
|
Crime Victims HV 6250-6250.4
|
|
Crisis intervention WM 401
|
|
Psychological aspects (General) WM 165
|
|
|
|
Critical Pathways W 84.7
|
|
In nursing WY 100
|
|
|
|
Cultural Diversity
|
|
Personnel management HF 5549.5.M5
|
|
As social factor in public health WA 30
|
|
Special topics, by subject
|
|
|
|
Decompression, Surgical WO 500
|
|
Localized, by site
|
|
For special purposes, by subject
|
|
|
|
Defibrillators, Implantable WG 330
|
|
|
|
Delivery of Health Care, Integrated W 84
|
|
|
|
Dental Audit WU 29
|
|
Of a hospital dental service WU 27
|
|
|
|
Dental Care for Children WU 480
|
|
|
|
<em>Dental Care for Chronically Ill WU 460</em>
|
|
|
|
Dental Implants, Single-Tooth WU 640
|
|
|
|
Dental Prosthesis, Implant-Supported WU 500-530
|
|
|
|
Dental Research WU 20.5
|
|
|
|
Dental Restoration Failure
|
|
Dental Prosthesis WU 500-530
|
|
Dental Restoration WU 300-360
|
|
|
|
Dentist's Practice Patterns WU 29
|
|
|
|
Dentition, Permanent WU 210
|
|
|
|
Depression, Postpartum WQ 500
|
|
|
|
Dietary Sucrose QU 83
|
|
As a sweetening agent WA 712
|
|
|
|
Disease Management W 84.7
|
|
|
|
DNA Footprinting
|
|
As a genetic technique QH 441
|
|
|
|
DNA Methylation QU 58.5
|
|
|
|
Drug Resistance, Neoplasm
|
|
In drug therapy (General) QZ 267
|
|
In particular neoplasms, with the neoplasm
|
|
See also Antineoplastic Agents QV 269, etc.
|
|
|
|
Drugs, Essential
|
|
General works QV 704
|
|
Economic aspects QV 736
|
|
|
|
Echocardiography, Four-Dimensional WG 141.5.E2
|
|
|
|
Echocardiography, Three-Dimensional WG 141.5.E2
|
|
|
|
Educational Technology LB 1028.3
|
|
Special topics, by subject
|
|
|
|
Embolism, Paradoxical WG 540
|
|
|
|
Embolization, Therapeutic
|
|
General works WH 310
|
|
Performed in interventional radiology WN 200
|
|
Used for the control of operative hemorrhage WO 500
|
|
Used for particular diseases, with the disease
|
|
See also Hemostasis, Surgical WO 500, etc.;
|
|
Hemostatic Techniques WH 310
|
|
|
|
Empiricism
|
|
Medical philosophy
|
|
History (Ancient) WZ 51
|
|
|
|
Enamel Microabrasion WU 220
|
|
|
|
Endemic Diseases WA 105
|
|
Statistics and surveys WA 900
|
|
Specific diseases, with the disease
|
|
|
|
Endosonography WN 208
|
|
Used for special purposes, by subject
|
|
|
|
Endotoxemia WC 240
|
|
|
|
Entropy
|
|
Biochemistry QU 34
|
|
Physics QC 318.E57
|
|
|
|
Environmental Illness
|
|
General WA 30.5
|
|
Due to specific etiology, by subject, e.g.,
|
|
Food Hypersensitivity WD 310;
|
|
Air Pollution, Indoor WA 754
|
|
|
|
<em>Environmental Medicine WA 30.5</em>
|
|
|
|
Ethnobotany GN 476.73
|
|
In medicine
|
|
Plants, Medicinal QV 766-770
|
|
Medicine, Traditional WB 50
|
|
History WZ 309
|
|
|
|
Evidence-Based Medicine WB 102
|
|
|
|
Evolution, Molecular
|
|
In biogenesis QH 325
|
|
See also Evolution QH 359-425, etc.;
|
|
Genetics QH 426-470, etc.;
|
|
Molecular Biology QH 506
|
|
|
|
Expressed Emotion BF 531-593
|
|
Specific emotions, with the emotion
|
|
Towards patients with specific disorders, with the disorder
|
|
|
|
Facies
|
|
General physiology WE 705
|
|
Characteristic of a disease, with the disease
|
|
|
|
Fat Substitutes QU 86
|
|
|
|
Feminism HQ 1101-1870.9
|
|
|
|
Financial Support
|
|
For health planning WA 525-546
|
|
For research (Form number 20-20.5 in any NLM schedule
|
|
where applicable)
|
|
For training (Form number 18 in any NLM schedule where
|
|
applicable)
|
|
See also Health Planning Support; Research Support;
|
|
Training Support
|
|
|
|
Food Packaging
|
|
Chemical technology TP 374
|
|
Public health aspects WA 695-722
|
|
|
|
Galanin WL 104
|
|
|
|
Granulocyte Colony-Stimulating Factor WH 200
|
|
|
|
Grave Robbing WZ 320
|
|
|
|
Hair Follicle WR 450
|
|
|
|
Health Care Surveys W 84.3
|
|
|
|
Health Food
|
|
Nutritive value QU 145.5
|
|
Public health aspects WA 695-722
|
|
|
|
Health Personnel W 21
|
|
For the availability and distribution of health
|
|
personnel see Health Manpower W 76
|
|
See also names of specific types of personnel, e.g.,
|
|
Allied Health Personnel W 21.5
|
|
|
|
Health Transition
|
|
Epidemiology WA 105
|
|
Statistics WA 900
|
|
Special population groups WA 300-395
|
|
|
|
Heat Stress Disorders WD 610
|
|
|
|
Heat Stroke WD 610
|
|
See also Sunstroke WD 610
|
|
|
|
Heat-Shock Response QT 120
|
|
See also Heat-Shock Proteins QU 55
|
|
|
|
Hematologic Neoplasms WH 525
|
|
Clinical pathology QZ 350
|
|
|
|
Hemorrhagic Fever, Ebola WC 534
|
|
|
|
Hemostatic Techniques WH 310
|
|
See also Embolization, Therapeutic WH 310, etc.
|
|
|
|
Hepatitis Agents, GB QW 170
|
|
|
|
High-Energy Shock Waves
|
|
Therapeutic use WB 480
|
|
Used for special purposes, by subject
|
|
See also Lithotripsy WJ 166, etc.
|
|
|
|
HIV Enteropathy WC 503.5
|
|
|
|
HIV Wasting Syndrome WC 503.5
|
|
|
|
Holistic Nursing
|
|
General WY 86.5
|
|
|
|
Hyperinsulinemia WK 880
|
|
|
|
Hypermedia
|
|
In medicine (General) W 26.55.S6
|
|
In other special fields (Form number 26.5 in any NLM
|
|
schedule where applicable)
|
|
|
|
Ilizarov Technique
|
|
Bone lengthening WE 168
|
|
Fracture fixation WE 185
|
|
See also names of particular bones, joints, or conditions
|
|
|
|
<em>Imagery (Psychotherapy) WM 420.5.I3</em>
|
|
|
|
Immunity, Mucosal
|
|
General QW 563
|
|
|
|
<em>Immunophenotyping QW 525.5.I36</em>
|
|
|
|
Infection Control, Dental WU 29
|
|
|
|
Information Management
|
|
General works Z 665+
|
|
Special topics, by subject
|
|
|
|
Insurance Coverage
|
|
General HG 8011-9343
|
|
Health insurance W 100-275
|
|
See also names of specific types of insurance, e.g.,
|
|
Medicare WT 31
|
|
|
|
Integrase QU 141
|
|
|
|
Intellectual Property
|
|
Copyright Z 551-656
|
|
Patents T 201-342
|
|
|
|
Intuition BF 315.5
|
|
|
|
Iron, Dietary
|
|
Biochemistry QU 130.5
|
|
Pharmacology QV 183
|
|
|
|
<em>Iron Metabolism Disorders WD 200.5.I7</em>
|
|
|
|
Iron Overload WD 200.5.I7
|
|
|
|
Ischemic Preconditioning QZ 170
|
|
Localized, by site
|
|
See also Ischemic Preconditioning, Myocardial WG 300
|
|
|
|
Ischemic Preconditioning, Myocardial WG 300
|
|
|
|
Jaw Fixation Techniques WU 610
|
|
|
|
Keratectomy, Photorefractive, Excimer Laser WW 220
|
|
|
|
Kinesiology, Applied WB 890
|
|
Used for particular disorders, with the disorder
|
|
|
|
Lactic Acid QU 98
|
|
|
|
Landau-Kleffner Syndrome WL 340.5
|
|
|
|
Leukostasis WH 200
|
|
|
|
Library Materials
|
|
Acquisition and selection Z 689-689.8
|
|
Cataloging Z 693-695.83
|
|
Classification Z 696-697
|
|
Medicine Z 697.M4
|
|
Collection development Z 687
|
|
Library bookbinding Z 700
|
|
Preservation Z 700.9-701.5
|
|
|
|
Liver, Artificial WI 770
|
|
|
|
Living Donors QS 523-524
|
|
Of specific organs, with the organ
|
|
|
|
Managed Competition
|
|
Economic aspects W 74
|
|
Related to managed care W 130
|
|
|
|
Mandatory Reporting
|
|
Of child abuse WA 320
|
|
Legislation WA 32-33
|
|
Of elder abuse WT 30
|
|
Legislation WT 32-33
|
|
|
|
Marfan Syndrome WD 375
|
|
|
|
Medical Errors
|
|
In the practice of medicine (General) WB 100
|
|
In operative surgery WO 500
|
|
In particular areas, by subject
|
|
See also Diagnostic Errors WB 141;
|
|
Medication Errors QZ 42, etc.
|
|
|
|
Medical Staff, Hospital WX 203
|
|
|
|
See also Medical Staff W 84;
|
|
Personnel, Hospital WX 159;
|
|
names of specific types of hospitals
|
|
|
|
Medicine, Unani WZ 80.5.A8
|
|
Currently practiced WB 50
|
|
Herbal medicine WB 925
|
|
|
|
Meditation
|
|
Behavior therapy WM 425.5.R3
|
|
Hygiene QT 265
|
|
Physical therapy WB 545
|
|
Transcendental meditation (Psychology) BF 637.T68
|
|
|
|
Megestrol WP 530
|
|
Used for special purposes, by subject
|
|
|
|
Mental Competency
|
|
Competency to consent in the acceptance of health care
|
|
W 85
|
|
Legal aspects W 32-33
|
|
Related to the mentally ill WM 32-33
|
|
|
|
Metaphor
|
|
In psychoanalysis WM 460.5.D8
|
|
In psychotherapy WM 420
|
|
In other specific subjects, with the subject
|
|
|
|
Micronutrients
|
|
Biochemistry QU 130.5
|
|
Analytical chemistry QD 139.T7
|
|
|
|
Mind-Body Relations (Metaphysics)
|
|
In alternative medicine WB 880
|
|
|
|
Mineral Fibers
|
|
Biochemistry QU 130
|
|
As environmental air pollutants WA 754
|
|
Causing a specific disease, with the disease
|
|
|
|
Mosses QK 534-549.5
|
|
|
|
Motor Neuron Disease WE 550
|
|
|
|
Motor Vehicles TL 1-390
|
|
Accidents WA 275
|
|
Air pollution WA 754
|
|
Human engineering in design TL 250
|
|
Noise hazard WA 776
|
|
See also specific type of vehicles, e.g., Ambulances
|
|
WX 215, etc.
|
|
|
|
Multilingualism
|
|
In language development WS 105.5.C8
|
|
|
|
Multimedia
|
|
(Form number 18.2 in any NLM schedule where applicable)
|
|
Special topics, by subject
|
|
|
|
Muscle Neoplasms WE 550
|
|
|
|
Muscle Weakness WE 550
|
|
|
|
Myocardial Ischemia WG 300
|
|
|
|
Neck Pain WE 708
|
|
|
|
Neovascularization, Physiologic WG 500
|
|
|
|
Neuromuscular Blockade
|
|
In surgery WO 234
|
|
|
|
No-Observed-Adverse-Effect Level QV 602
|
|
Of specific drugs, with the drug
|
|
|
|
Nucleic Acid Synthesis Inhibitors QU 58
|
|
|
|
Observation
|
|
As a scientific method in research (Form number 20 or
|
|
20.5 in any NLM schedule where applicable)
|
|
In specific topics, by subject
|
|
|
|
Occlusal Adjustment WU 440
|
|
|
|
Okadaic Acid
|
|
As an enzyme inhibitor QU 143
|
|
|
|
Optic Neuropathy, Ischemic WW 280
|
|
|
|
Oral Ulcer WU 140
|
|
|
|
Orphanages HV 959-1420.5
|
|
|
|
Ossification of Posterior Longitudinal Ligament WE 725
|
|
|
|
Osteotomy, Le Fort WU 610
|
|
|
|
Ovulation Detection WP 540
|
|
|
|
Paclitaxel
|
|
Pharmacology QV 269
|
|
Therapeutic use QZ 267
|
|
|
|
Pancreas, Artificial WI 830
|
|
|
|
Pancreatitis, Alcoholic WI 805
|
|
|
|
Pelvic Pain WP 155
|
|
|
|
Peroxisomal Disorders WD 205.5.L5
|
|
|
|
Persian Gulf Syndrome
|
|
Veterans' broad health care issues UB 368-369.5
|
|
Psychological aspects WM 170-184
|
|
Particular disorders, with the disorder
|
|
|
|
Phacoemulsification WW 260
|
|
|
|
Phantoms, Imaging WN 150
|
|
|
|
Physician-Nurse Relations
|
|
From the physician's perspective W 62
|
|
From the nurse's perspective WY 87
|
|
|
|
Point-of-Care Systems
|
|
In hospitals (General) WX 162
|
|
Special topics, by subject
|
|
|
|
Portasystemic Shunt, Transjugular Intrahepatic WI 720
|
|
|
|
Postoperative Hemorrhage WO 184
|
|
|
|
Pregnancy Rate HB 901-1108
|
|
|
|
[original text intentionally deleted 1998/03/26]
|
|
|
|
Privacy
|
|
Applied psychology BF 637.P74
|
|
Medical records confidentiality WX 173
|
|
Special topics, by subject
|
|
See also Civil Rights
|
|
|
|
Quality-Adjusted Life Years
|
|
Demography HB 1322
|
|
Special topics, by subject
|
|
See also Quality of Life WA 30
|
|
|
|
Racquet Sports QT 260.5.R2
|
|
|
|
Radiovisiography, Dental WN 230
|
|
|
|
<em>Rehabilitation Nursing WY 150.5</em>
|
|
Of particular diseases, with the nursing number for the
|
|
disease
|
|
|
|
Renal Agents
|
|
Therapeutic use WJ 166
|
|
See also Anti-Infective Agents, Urinary QV 243;
|
|
Diuretics QV 160;
|
|
Uricosuric Agents QV 98
|
|
|
|
Reproduction Techniques WQ 208
|
|
|
|
Reproductive History WQ 205
|
|
|
|
Rescue Work
|
|
First aid WA 292
|
|
Medical emergencies WB 105
|
|
For specific conditions, by subject
|
|
|
|
Resin Cements WU 190
|
|
|
|
Respiratory System Agents QV 120
|
|
See also specific kinds of agents, e.g.,
|
|
Antitussive Agents QV 76, etc.
|
|
|
|
Retinal Perforations WW 270
|
|
|
|
Retreatment
|
|
Of a particular disease, with the disease
|
|
|
|
Rhizotomy WL 368
|
|
|
|
RNA, Satellite QU 58.7
|
|
|
|
Rural Health Services WA 390
|
|
|
|
Safety Management
|
|
General WA 250-288
|
|
In hospitals WX 185
|
|
In occupational settings WA 485-491
|
|
Radiation WN 650
|
|
In specific types of facilities, class with type of
|
|
facility in the number for administration if number
|
|
for safety or accident prevention is
|
|
unavailable; in the general works number if both are
|
|
lacking
|
|
|
|
Salivary Ducts WI 230
|
|
|
|
Self Psychology WM 460.5.E3
|
|
See also Self Concept BF 697, etc.
|
|
|
|
Sepsis WC 240
|
|
|
|
Sexuality
|
|
Human HQ 12-449
|
|
In adolescence WS 462
|
|
In infancy & childhood WS 105.5.S4
|
|
Psychology BF 692
|
|
|
|
Shamanism
|
|
Alternative medicine WB 885
|
|
History WZ 309
|
|
|
|
Shoulder Impingement Syndrome WE 810
|
|
|
|
Single-Payer System W 100-275
|
|
|
|
Skull Base WE 705
|
|
|
|
Skull Base Neoplasms WE 707
|
|
|
|
Solar Activity QB 524-526
|
|
|
|
Somatropin WK 515
|
|
Deficiency WK 550
|
|
As a cause of a particular disorder, with the
|
|
disorder
|
|
|
|
Soy Proteins QU 55
|
|
As a supplement in health or disease WB 430
|
|
Cookery for protein control WB 430
|
|
|
|
Space Suits TL 1550
|
|
In space medicine WD 750-758
|
|
|
|
Spectroscopy, Near-Infrared
|
|
General qualitative and quantitative analysis QD 96.I5
|
|
Organic analysis QD 272.S6
|
|
Food analysis TX 547.2.I53
|
|
Used for special purposes, by subject
|
|
|
|
Stethoscopes WB 26
|
|
See also Auscultation WB 278
|
|
|
|
Stomatognathic Diseases WU 140
|
|
|
|
Stomatognathic System
|
|
Anatomy WU 101
|
|
Abnormalities WU 101.5
|
|
Pathology WU 140
|
|
Physiology WU 102
|
|
Surgery WU 600
|
|
|
|
Streptococcus oralis QW 142.5.C6
|
|
|
|
Subacute Care WX 162-162.5
|
|
Nursing WY 152
|
|
Pediatric WY 159
|
|
Of a particular disease, with the disease
|
|
|
|
Substance Abuse Treatment Centers WM 29
|
|
|
|
Suburban Health WA 300
|
|
|
|
Suburban Health Services W 84-84.8
|
|
See also Community Health Services WA 546
|
|
|
|
Suicide, Attempted HV 6543-6548
|
|
Psychiatric aspects WM 165
|
|
Specific disorders associated with attempted suicide,
|
|
with the disorder
|
|
See also Crisis Intervention WM 401
|
|
|
|
Superantigens QW 573
|
|
|
|
Surgery, Endoscopic
|
|
General works WO 505
|
|
For specific diseases or regions, with the disease or
|
|
region
|
|
|
|
Surgery, Minimally Invasive
|
|
General works WO 505
|
|
For specific diseases or regions, with the disease or
|
|
region
|
|
|
|
Tax Exemption HJ 2336-2337
|
|
Hospitals WX 157
|
|
In other fields, in practice management or economics
|
|
number by subject
|
|
|
|
Technology, Medical Laboratory
|
|
As a profession QY 21
|
|
Clinical pathology QY
|
|
Diagnostic and therapeutic techniques QY 25
|
|
See also Diagnosis, Laboratory QY, etc.
|
|
|
|
Telemedicine
|
|
General works W 83
|
|
In private practice WB 50
|
|
In particular subjects, by subject
|
|
|
|
Telepathology QY 25
|
|
|
|
Teleradiology WN 160
|
|
|
|
Temporomandibular Joint Disk WU 101-102
|
|
|
|
Terminally Ill
|
|
In infancy and childhood WS 200
|
|
Medical aspects WB 310
|
|
Nursing WY 152
|
|
With a particular disease, with the disease
|
|
|
|
Therapeutic Touch WB 890
|
|
|
|
Tobacco Industry HD 9130-9149
|
|
|
|
Tooth Attrition WU 140
|
|
|
|
Tooth Preparation WU 300
|
|
|
|
Tooth Preparation, Prosthodontic WU 500
|
|
|
|
Topography, Medical WB 700-710
|
|
Of specific diseases, with the disease
|
|
See also Epidemiology WA 900, etc.
|
|
|
|
Toxicity Tests QV 602
|
|
For specific drugs, with the drug
|
|
|
|
Transplantation Conditioning WO 680
|
|
Used for special purposes, by subject, e.g., Bone
|
|
Marrow Transplantation WH 380
|
|
|
|
Trauma Centers WX 215
|
|
|
|
Ultrasonography, Mammary WP 815
|
|
|
|
Universal Coverage W 100-275
|
|
See also names of specific types ofinsurance, e.g.,
|
|
Medicare WT 31
|
|
|
|
Urban Health Services WA 380
|
|
|
|
Vaccines, DNA QW 805
|
|
|
|
Vaginal Discharge WP 255
|
|
|
|
Vascular Capacitance WG 106
|
|
|
|
Vascular Neoplasms
|
|
General works WG 500
|
|
In arteries WG 510
|
|
In veins WG 600
|
|
In coronary vessels WG 300
|
|
|
|
Vegetable Proteins QU 55
|
|
As a supplement in health or disease WB 430
|
|
Cookery WB 430
|
|
|
|
Veterinary Drugs SF 917
|
|
See also Veterinary SF 915
|
|
under Pharmacology
|
|
|
|
Vocabulary, Controlled Z 695-695.1
|
|
Medicine Z 695.1.M48
|
|
|
|
Wasting Syndrome WB 146
|
|
Associated with nutrition disorders WD 100
|
|
In infancy & childhood WS 115
|
|
In connection with specific diseases, with the disease
|
|
See also HIV Wasting Syndrome WC 503.5
|
|
|
|
Women's Health Services
|
|
General WA 309
|
|
|
|
Zebrafish QL 638.C94
|
|
|
|
|
|
<strong>Notable Changes in the Index</strong>
|
|
|
|
Note: Minor changes such as adding subindexes under specific
|
|
existing Index terms are not listed in this chart.
|
|
|
|
|
|
<strong>Page Reference Change</strong>
|
|
|
|
p. I-81 under Embryo change classification no.
|
|
Transfer at sub-index from: WQ 205 to: WQ 208
|
|
Human
|
|
|
|
p. I-86 at Epithalamus change entire line to:
|
|
see Diencephalon Epithalamus WL 312
|
|
|
|
p. I-93 at Fertilization change classification no.
|
|
in Vitro from: WQ 205 to: WQ 208
|
|
|
|
p. I-100 under Gamete change classification no.
|
|
Intrafallopian Transfer from: WQ 205 to: WQ208
|
|
at sub-index Human
|
|
|
|
p. I-106 at GTP-Binding change entire line to:
|
|
proteins see G-Proteins GTP-Binding Proteins QU 55
|
|
|
|
p. I-129 at Insurance, change to: Insurance,
|
|
Disability see Medicare Disability HD 7105.2-7105.25
|
|
Medicare WT 31
|
|
|
|
p. I-187 at Photons change to: Photons
|
|
see Radiation Physics QC 793.5.P42-
|
|
793.5.P429
|
|
Radiation effects of
|
|
WN 600-630
|
|
Special topics, by subject
|
|
|
|
p. I-233 under Surgery, change classification no.
|
|
Laparoscopic at sub-index from: WO 500 to: WO 505
|
|
General works
|
|
|
|
p. I-236 at Technology, replace the entire Index entry
|
|
Medical with:
|
|
Technology, Medical
|
|
General works W 82
|
|
Diagnostic and therapeutic
|
|
techniques WB 365
|
|
Economic aspects W 74
|
|
Instrumentation (General)
|
|
W 26
|
|
In special fields (Form
|
|
number 26 in any NLM
|
|
schedule where applicable)
|
|
Special topics, by subject
|
|
</pre>
|
|
|
|
|
|
|
|
|
|
|
|
</td>
|
|
|
|
|
|
|
|
|
|
|
|
<tr><td valign=top bgcolor="#CB9966" width=140><a href="/pubs/techbull/nd97/nd97_technote.html">Next article</a>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
|
|
<a href="/pubs/techbull/nd97/nd97_class.html">Table of contents</a>
|
|
|
|
|
|
</p>
|
|
|
|
<p>
|
|
<a href="/pubs/techbull/tb.html">Home</a>
|
|
</p>
|
|
|
|
<p>
|
|
<a href="/pubs/techbull/new_index.html">Index</a>
|
|
</p>
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
|
|
<br />
|
|
<hr />
|
|
<!-- BEGIN NLM FOOTER -->
|
|
<center>
|
|
<font size="2" face="helvetica, arial"><a href="/nlmhome.html">U.S. National Library of Medicine</a>, 8600 Rockville Pike, Bethesda, MD 20894<br /><a href="http://www.nih.gov/">National Institutes of Health</a>, <a href="//www.hhs.gov/">Department of Health & Human Services</a><br /><a href="/copyright.html">Copyright</a>, <a href="/privacy.html">Privacy</a>, <a href="/accessibility.html">Accessibility</a>, <a href="http://www.nih.gov/icd/od/foia/index.htm">Freedom of Information Act (FOIA)</a><br/><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">HHS Vulnerability Disclosure</a>
|
|
<br />
|
|
<!-- ******************MODIFY "LAST UPDATED" ******************* -->
|
|
Last updated: 18 April 2012
|
|
</font>
|
|
</center>
|
|
|
|
<!-- END NLM FOOTER -->
|
|
<!-- ******************MODIFY EXPDATE AND EMAIL BELOW****************** -->
|
|
<!-- EXPDATE="2015-03-20" -->
|
|
<!-- EMAIL="nlmtechbull@mail.nlm.nih.gov" -->
|
|
<script src="//assets.nlm.nih.gov/jquery/jquery-latest.min.js"></script><script src="/core/nlm-notifyExternal/1.0/nlm-notifyExternal.min.js"></script></body>
|
|
</html>
|
|
|